DcpS as a Therapeutic Target for Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is caused by deletion or mutation of both copies of the SMN1 gene which produces an essential protein known as SMN. The severity of SMA is modified by variable copy number of a second gene, SMN2 that produces an mRNA that is incorrectly spliced with deletion of the last...

Full description

Saved in:

Bibliographic Details
Main Authors:	Singh, Jasbir, Salcius, Michael, Liu, Shin-Wu, Staker, Bart L., Mishra, Rama, Thurmond, John, Michaud, Gregory, Mattoon, Dawn R., Printen, John, Pollok, Brian A., Kiledjian, Megerditch, Christensen, Jeffery, Stewart, Lance, Jarecki, Jill, Bjornsson, Jon Mar, Gurney, Mark E
Format:	Artigo
Language:	Inglês
Published:	2008
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2646632/ https://ncbi.nlm.nih.gov/pubmed/18839960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cb800120t
Tags:	Add Tag No Tags, Be the first to tag this record!

DcpS as a Therapeutic Target for Spinal Muscular Atrophy

Similar Items